open access

Vol 12, No 2 (2017)
Review paper
Published online: 2017-04-20
Get Citation

Factors affecting rehospitalizations of heart failure patients

Przemysław Szeląg, Maria Kuśnierz, Maria Łoboz-Rudnicka, Beata Jankowska-Polańska, Joanna Jaroch, Izabella Uchmanowicz
DOI: 10.5603/FC.2017.0024
·
Folia Cardiologica 2017;12(2):162-170.

open access

Vol 12, No 2 (2017)
Review Papers
Published online: 2017-04-20

Abstract

Heart failure (HF) is at present an important clinical problem. Hospitalization of HF patients causes that they have a much less favorable prognosis, and their successive rehospitalizations significantly affect the course of the disease and further treatment. The main reason for readmission to hospital is HF exacerbation, which from the pathophysiological point of view is associated with an elevated pressure in the pulmonary circulation. Factors affecting rehospitalization can be divided into: cardiac-related factors such as ischemia, atrial fibrillation, and uncontrolled hypertension, non-cardiac factors including coexisting diseases (especially chronic obstructive pulmonary disease, infections), patient- -related factors (nonadherence/noncompliance, self-care, frailty-syndrome, depression, cachexia) and healthcare system-related factors (nonadherence of physicians, therapeutic nihilism, insufficiency of interdisciplinary care system in the field of patients’ therapy and education). Rehospitalization of HF patients is a complex, multifactorial and not fully understood problem. An integrated interdisciplinary care system, which covers patients’ therapy, education, self- -assessment and self-control may reduce the mortality rate and number of rehospitalizations for all reasons and for HF.

Abstract

Heart failure (HF) is at present an important clinical problem. Hospitalization of HF patients causes that they have a much less favorable prognosis, and their successive rehospitalizations significantly affect the course of the disease and further treatment. The main reason for readmission to hospital is HF exacerbation, which from the pathophysiological point of view is associated with an elevated pressure in the pulmonary circulation. Factors affecting rehospitalization can be divided into: cardiac-related factors such as ischemia, atrial fibrillation, and uncontrolled hypertension, non-cardiac factors including coexisting diseases (especially chronic obstructive pulmonary disease, infections), patient- -related factors (nonadherence/noncompliance, self-care, frailty-syndrome, depression, cachexia) and healthcare system-related factors (nonadherence of physicians, therapeutic nihilism, insufficiency of interdisciplinary care system in the field of patients’ therapy and education). Rehospitalization of HF patients is a complex, multifactorial and not fully understood problem. An integrated interdisciplinary care system, which covers patients’ therapy, education, self- -assessment and self-control may reduce the mortality rate and number of rehospitalizations for all reasons and for HF.

Get Citation

Keywords

heart failure, rehospitalizations

About this article
Title

Factors affecting rehospitalizations of heart failure patients

Journal

Folia Cardiologica

Issue

Vol 12, No 2 (2017)

Article type

Review paper

Pages

162-170

Published online

2017-04-20

DOI

10.5603/FC.2017.0024

Bibliographic record

Folia Cardiologica 2017;12(2):162-170.

Keywords

heart failure
rehospitalizations

Authors

Przemysław Szeląg
Maria Kuśnierz
Maria Łoboz-Rudnicka
Beata Jankowska-Polańska
Joanna Jaroch
Izabella Uchmanowicz

References (64)
  1. McMurray JJV, Adamopoulos S, Anker SD, et al. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, ESC Committee for Practice Guidelines, ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012; 33(14): 1787–1847.
  2. Go AS, Mozaffarian D, Roger VL, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics — 2013 update: a report from the American Heart Association. Circulation. 2013; 127(1): e6–e245.
  3. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014; 63(12): 1123–1133.
  4. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007; 93(9): 1137–1146.
  5. Fonarow GC, Stough WG, Abraham WT, et al. OPTIMIZE-HF Investigators and Hospitals. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007; 50(8): 768–777.
  6. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14): 1418–1428.
  7. O'Connor CM, Miller AB, Blair JEA, et al. Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010; 159(5): 841–849.e1.
  8. Adams KF, Fonarow GC, Emerman CL, et al. ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149(2): 209–216.
  9. Gheorghiade M, Filippatos G, De Luca L, et al. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006; 119(12 Suppl 1): S3–SS10.
  10. Gattis WA, O'Connor CM, Gattis WA, et al. IMPACT-HF Investigators and Coordinators. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial. J Am Coll Cardiol. 2004; 43(9): 1534–1541.
  11. Gheorghiade M, Pang PS, Ambrosy AP, et al. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012; 17(3): 485–509.
  12. Hernandez MB, Schwartz RS, Asher CR, et al. Predictors of 30-day readmission in patients hospitalized with decompensated heart failure. Clin Cardiol. 2013; 36(9): 542–547.
  13. Komukai K, Ogawa T, Yagi H, et al. Decreased renal function as an independent predictor of re-hospitalization for congestive heart failure. Circ J. 2008; 72(7): 1152–1157.
  14. Braunstein JB, Anderson GF, Gerstenblith G, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol. 2003; 42(7): 1226–1233.
  15. Uchmanowicz I, Łoboz-Rudnicka M, Szeląg P, et al. Frailty in heart failure. Curr Heart Fail Rep. 2014; 11(3): 266–273.
  16. McNallan SM, Singh M, Chamberlain AM, et al. Frailty and healthcare utilization among patients with heart failure in the community. JACC Heart Fail. 2013; 1(2): 135–141.
  17. Lupón J, González B, Santaeugenia S, et al. Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol. 2008; 61(8): 835–842.
  18. Newman AB, Gottdiener JS, Mcburnie MA, et al. Cardiovascular Health Study Research Group. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci. 2001; 56(3): M158–M166.
  19. Zaslavsky O, Woods NF, LaCroix AZ, et al. Women's Health Initiative Observational Study, Women's Health Initiative, Women's Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2005; 53(8): 1321–1330.
  20. Cacciatore F, Abete P, Mazzella F, et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2005; 35(12): 723–730.
  21. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014; 63(8): 747–762.
  22. Pulignano G, Del Sindaco D, Di Lenarda A, et al. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med (Hagerstown). 2010; 11(10): 739–747.
  23. Murad K, Kitzman DW. Frailty and multiple comorbidities in the elderly patient with heart failure: implications for management. Heart Fail Rev. 2012; 17(4-5): 581–588.
  24. Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008; 27(6): 793–799.
  25. von Haehling S, Jankowska EA, Morgenthaler NG, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997; 349(9058): 1050–1053.
  26. Uchmanowicz I, Gobbens RJJ. The relationship between frailty, anxiety and depression, and health-related quality of life in elderly patients with heart failure. Clin Interv Aging. 2015; 10: 1595–1600.
  27. Johnson TJ, Basu S, Pisani BA, et al. Depression predicts repeated heart failure hospitalizations. J Card Fail. 2012; 18(3): 246–252.
  28. Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003; 65(1): 119–128.
  29. Chaudhry SI, Wang Y, Gill TM, et al. Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol. 2010; 55(4): 309–316.
  30. Pressler SJ, Subramanian U, Kareken D, et al. Cognitive deficits in chronic heart failure. Nurs Res. 2010; 59(2): 127–139.
  31. Pullicino PM, Wadley VG, McClure LA, et al. Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail. 2008; 14(4): 290–295.
  32. Uchmanowicz I, Wleklik M, Gobbens RJJ. Frailty syndrome and self-care ability in elderly patients with heart failure. Clin Interv Aging. 2015; 10: 871–877.
  33. Dracup K, Baker DW, Dunbar SB, et al. Management of heart failure. II. Counseling, education, and lifestyle modifications. JAMA. 1994; 272(18): 1442–1446.
  34. Granger BB, Swedberg K, Ekman I, et al. CHARM investigators. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005; 366(9502): 2005–2011.
  35. Jaarsma T, Halfens R, Huijer Abu-Saad H, et al. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J. 1999; 20(9): 673–682.
  36. Lee CS, Moser DK, Lennie TA, et al. Event-free survival in adults with heart failure who engage in self-care management. Heart Lung. 2011; 40(1): 12–20.
  37. Lainscak M, Blue L, Clark AL, et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2011; 13(2): 115–126.
  38. Moser DK, Dickson V, Jaarsma T, et al. Role of self-care in the patient with heart failure. Curr Cardiol Rep. 2012; 14(3): 265–275.
  39. Uchmanowicz I, Loboz-Rudnicka M, Jaarsma T, et al. Cross-cultural adaptation and reliability testing of Polish adaptation of the European Heart Failure Self-care Behavior Scale (EHFScBS). Patient Prefer Adherence. 2014; 8: 1521–1526.
  40. van der Wal MHL, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol. 2008; 125(2): 203–208.
  41. Nieuwenhuis MMW, Jaarsma T, van Veldhuisen DJ, et al. Long-term compliance with nonpharmacologic treatment of patients with heart failure. Am J Cardiol. 2012; 110(3): 392–397.
  42. Nieuwenhuis MMW, Jaarsma T, van Veldhuisen DJ, et al. Compliance with non-pharmacological recommendations and outcome in heart failure patients. Eur Heart J. 2010; 31(12): 1486–1493.
  43. Davies EJ, Moxham T, Rees K, et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail. 2010; 12(7): 706–715.
  44. Paterna S, Gaspare P, Fasullo S, et al. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008; 114(3): 221–230.
  45. Evangelista LS, Berg J, Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung. 2001; 30(4): 294–301.
  46. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998; 158(16): 1769–1776.
  47. Murray MD, Tu W, Wu J, et al. Factors associated with exacerbation of heart failure include treatment adherence and health literacy skills. Clin Pharmacol Ther. 2009; 85(6): 651–658.
  48. Toh C, Jackson B, Gascard D, et al. Barriers to medication adherence in chronic heart failure patients during home visits. J Pharm Pract Res. 2010; 40(1): 27–30.
  49. Cholowski K, Cantwell R. Predictors of medication compliance among older heart failure patients. Int J Older People Nurs. 2007; 2(4): 250–262.
  50. Nieuwenhuis MMW, Jaarsma T, van Veldhuisen DJ, et al. Factors associated with patient delay in seeking care after worsening symptoms in heart failure patients. J Card Fail. 2011; 17(8): 657–663.
  51. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119(23): 3028–3035.
  52. Mockler M, O'Loughlin C, Murphy N, et al. Causes and consequences of nonpersistence with heart failure medication. Am J Cardiol. 2009; 103(6): 834–838.
  53. Cleland JGF, Cohen-Solal A, Aguilar JC, et al. IMPROVEMENT of Heart Failure Programme Committees and Investigators. Improvement programme in evaluation and management, Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002; 360(9346): 1631–1639.
  54. Rywik TM, Rywik SL, Korewicki J, et al. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns. Int J Cardiol. 2004; 95(2-3): 177–184.
  55. Westheim A, Dickstein K, Gundersen T, et al. The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J. 1997; 18(5): 736–753.
  56. Belzunce FJ, Ziadi A, Rodriguez C. Structural integrity of hot strip mill rolling rolls. Engineering Failure Analysis. 2004; 11(5): 789–797.
  57. Rabelo ER, Aliti GB, Domingues FB, et al. What to teach to patients with heart failure and why: the role of nurses in heart failure clinics. Rev Lat Am Enfermagem. 2007; 15(1): 165–170.
  58. Krumholz H, Amatruda J, Smith G, et al. Randomized trial of an education and support intervention to preventreadmission of patients with heart failure. Journal of the American College of Cardiology. 2002; 39(1): 83–89.
  59. McDonald K, Ledwidge M, Cahill J, et al. Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail. 2002; 8(3): 142–148.
  60. Wierzchowiecki M, Poprawski K, Nowicka A, et al. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up. Kardiol Pol. 2006; 64(10): 1063–70; discussion 1071.
  61. Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail. 2005; 7(7): 1133–1144.
  62. McAlister FA, Stewart S, Ferrua S, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004; 44(4): 810–819.
  63. Strömberg A. The crucial role of patient education in heart failure. Eur J Heart Fail. 2005; 7(3): 363–369.
  64. van der Wal MH, Jaarsma T, Moser DK, et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006; 27(4): 434–440.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl